Hassan Boroujerdi-Rad, MD
Nephrology · Whittier
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 51 years
- Graduated 1975
Offices
1 location · Whittier Internal Medicine and Nephrology Medical Group Inc · 7 clinicians in this group
Looking this up.
Hospitals listed: 052712 · 052884 · Pih Health Hospital-Whittier · Whittier Hospital Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Boroujerdi-Rad’s office at (562) 698-8141 to ask if they take your plan before you enroll.
California Medical Board record
Licence A55053 · Current
Licensed to practise in California · since 1995 · expires 2027-10-31 · Tehran University of Medical Sciences and Health Services.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Pih Health Hospital-WhittierWhittier, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of PIH Health, which runs 3 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.497, Oct 2024 – Sep 2025
- Whittier Hospital Medical CenterWhittier, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.265, Oct 2024 – Sep 2025
See every measure and the patient survey for Pih Health Hospital-Whittier
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.497 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0 to 1.8) · 1,222 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.77 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.59 (122.43 to 208.75) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 323 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 360 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 553 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,869 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,090 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.56 (3.44 to 7.67) · 1,178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.98 (0.31 to 3.64) · 255 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (1.77 to 4.79) · 1,113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.32 (5.89 to 20.76) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.43 to 9.49) · 249 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.16 to 3.11) · 236 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.12 (0 to 0.71) · 5,179 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 140 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.594 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.825 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.474 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.445 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.39 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 509 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 1,125 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.1 · 147 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27 · 401 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30.4 · 400 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 1,019 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.4) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (10.4 to 18.1) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 222 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10.1 to 16.6) · 1,770 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 397 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,178 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Whittier Hospital Medical Center
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.265 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.1) · 342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.44 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.7 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 40 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.9 · 903 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.42) · 1,603 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,665 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.29 (0.73 to 5.86) · 153 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0 to 3.4) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.99 (0 to 18.96) · 36 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (0.88 to 9.55) · 32 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.32) · 1,393 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 63 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.575 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 191 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 2 · 101 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.3 · 199 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 319 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 71 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.7 to 17.8) · 98 cases | No different | Jan 2022 – Dec 2024 |
What patients said (540 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$75,614
Medicare paid this office $75,614 for 178 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $26,399 | $293 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $22,531 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,403 | $142 |
| Return visit (30+ min) | 50 | $7,198 | $76 |
| Short return visit (20+ min) | 11 | $610 | $55 |
Who their Medicare patients are
178 Original Medicare patients in 2024. Average age 74 · Under 65 17% · 85 and older 27% · Women 47% · Also on Medicaid 79% · Health risk score 4.30. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 70% · Heart failure 61% · Coronary heart disease 46% · Atrial fibrillation 44% · Depression 38% · Dementia 30% · Stroke 27% · COPD 26% · Cancer 17%.
The office billed $207,070, Medicare allowed $96,731 and paid $75,614; for 674 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 178 | 674 | 74 | 4.30 | $207,070 | $75,614 |
| 2023 | 162 | 718 | 73 | 5.05 | $221,640 | $84,488 |
| 2022 | 173 | 788 | 73 | 4.56 | $221,985 | $83,749 |
| 2021 | 156 | 658 | 73 | 4.46 | $213,155 | $82,856 |
| 2020 | 175 | 658 | 71 | 4.35 | $208,175 | $80,174 |
| 2019 | 178 | 658 | 72 | 4.53 | $164,225 | $65,209 |
| 2018 | 195 | 616 | 72 | 4.27 | $131,950 | $50,848 |
| 2017 | 219 | 1,217 | 71 | 4.72 | $503,475 | $178,627 |
| 2016 | 251 | 1,483 | 70 | 4.74 | $573,625 | $205,981 |
| 2015 | 247 | 1,643 | 70 | 4.77 | $626,400 | $231,088 |
| 2014 | 251 | 1,636 | 72 | 4.60 | $639,675 | $232,028 |
| 2013 | 281 | 2,038 | 72 | 4.24 | $736,450 | $262,572 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 12 | $30,659 | $298 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 87 | $24,726 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $7,701 | $145 |
| Return visit (30+ min) | 49 | $7,068 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,695 | $100 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 93 | $28,828 | $60 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 15 | $21,196 | $307 |
| Return visit (30+ min) | 41 | $8,378 | $105 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 16 | $8,167 | $255 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,858 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,696 | $87 |
2021: 6 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 15 | $27,778 | $316 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $17,294 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $11,270 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $7,065 | $89 |
| Return visit (30+ min) | 38 | $6,635 | $105 |
| Short return visit (20+ min) | 14 | $903 | $65 |
2020: 6 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 15 | $25,724 | $250 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $13,937 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $13,445 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $8,036 | $90 |
| Return visit (30+ min) | 37 | $4,343 | $87 |
| Short return visit (20+ min) | 34 | $2,520 | $63 |
2019: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 87 | $16,662 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $13,899 | $172 |
| Return visit (30+ min) | 52 | $8,409 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $6,144 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $4,763 | $88 |
| Short return visit (20+ min) | 35 | $2,665 | $61 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $15,836 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,164 | $164 |
| Return visit (30+ min) | 41 | $5,730 | $86 |
| Short return visit (20+ min) | 60 | $5,467 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $4,633 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $3,626 | $84 |
| New patient visit (45+ min) | 13 | $1,490 | $115 |
2017: 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 51 | $88,829 | $235 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 41 | $21,771 | $198 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $17,373 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 84 | $16,972 | $60 |
| Return visit (30+ min) | 63 | $9,439 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $6,885 | $86 |
| Short return visit (20+ min) | 46 | $3,531 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,592 | $113 |
2016: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 58 | $102,178 | $237 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 100 | $23,581 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $20,022 | $168 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 33 | $17,885 | $201 |
| Return visit (30+ min) | 69 | $10,670 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $7,770 | $86 |
| Short return visit (20+ min) | 42 | $3,098 | $61 |
| New patient visit (45+ min) | 18 | $2,503 | $139 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $2,273 | $114 |
2015: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 63 | $113,243 | $239 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $28,548 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $22,882 | $171 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $18,773 | $202 |
| Return visit (30+ min) | 89 | $14,279 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $12,257 | $88 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $3,132 | $157 |
| Short return visit (20+ min) | 37 | $2,818 | $59 |
| New patient visit (45+ min) | 16 | $2,097 | $131 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,724 | $115 |
2014: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 62 | $133,684 | $240 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $23,161 | $60 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $14,967 | $205 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $14,350 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $12,230 | $170 |
| Return visit (30+ min) | 72 | $9,655 | $92 |
| Short return visit (20+ min) | 80 | $6,587 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $4,029 | $115 |
| New patient visit (45+ min) | 19 | $2,672 | $141 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $1,882 | $157 |
2013: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 67 | $135,932 | $234 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 108 | $32,378 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $19,514 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $19,470 | $84 |
| Return visit (30+ min) | 81 | $12,824 | $90 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $10,865 | $198 |
| Short return visit (20+ min) | 93 | $8,622 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $4,462 | $112 |
| New patient visit (60+ min) | 12 | $1,980 | $165 |
Medicaid work
$1,990 in 2024
Medicaid paid $1,990 for 108 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 108 | $1,990 |
| 2024 | 108 | 1 | 13 | $1,990 |
| 2023 | 66 | 1 | 12 | $1,594 |
| 2020 | 58 | 1 | 22 | $1,557 |
| 2019 | 80 | 2 | 18 | $2,150 |
| 2018 | 58 | 2 | 14 | $993 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 66 | $1,594 |
2020
| Return visit (30+ min) | 58 | $1,557 |
2019
| Return visit (30+ min) | 44 | $1,531 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 36 | $618 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 46 | $768 |
| Return visit (30+ min) | 12 | $225 |
Drugs they prescribed that Part D paid
$340,499
Pharmacies billed $340,499 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,085 generic and fewer than 11 brand-name prescriptions · $340,499 in drug cost · 34 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 80 | $78,444 | $981 |
| Lokelma | 94 | $57,165 | $608 |
| Procrit | 60 | $48,577 | $810 |
| Jardiance | 20 | $21,249 | $1,062 |
| Calcium Acetate | 61 | $3,753 | $62 |
See all 27 drugs
| Farxiga | 80 | $78,444 | $981 |
| Lokelma | 94 | $57,165 | $608 |
| Procrit | 60 | $48,577 | $810 |
| Jardiance | 20 | $21,249 | $1,062 |
| Calcium Acetate | 61 | $3,753 | $62 |
| Clonidine | 23 | $3,192 | $139 |
| Nifedipine Er | 17 | $1,311 | $77 |
| Labetalol | 31 | $1,130 | $36 |
| Losartan | 118 | $1,035 | $9 |
| Cinacalcet | 12 | $919 | $77 |
| Amlodipine Besylate | 141 | $815 | $6 |
| Furosemide | 135 | $627 | $5 |
| Hydralazine | 35 | $547 | $16 |
| Potassium Chloride | 28 | $490 | $18 |
| Calcitriol | 17 | $318 | $19 |
| Benazepril | 27 | $285 | $11 |
| Lisinopril | 45 | $255 | $6 |
| Allopurinol | 28 | $229 | $8 |
| Carvedilol | 27 | $226 | $8 |
| Gabapentin | 27 | $187 | $7 |
| Hydrochlorothiazide | 47 | $186 | $4 |
| Metoprolol | 14 | $123 | $9 |
| Glipizide Er | 17 | $106 | $6 |
| Prednisone | 24 | $102 | $4 |
| Simvastatin | 13 | $89 | $7 |
| Atorvastatin | 22 | $88 | $4 |
| Ciprofloxacin | 14 | $28 | $2 |
Year by year
| 2024 | 1,439 | 277 | None | None | $340,499 |
| 2023 | 1,594 | 288 | None | None | $347,882 |
| 2022 | 1,430 | 266 | None | None | $156,834 |
| 2021 | 1,577 | 269 | None | None | $171,308 |
| 2020 | 1,792 | 266 | 1% (12) | 17% | $162,437 |
| 2019 | 1,997 | 272 | None | 15% | $217,767 |
| 2018 | 1,894 | 251 | None | 13% | $211,035 |
| 2017 | 2,293 | 271 | None | 19% | $347,383 |
| 2016 | 2,649 | 286 | None | 21% | $408,096 |
| 2015 | 3,193 | 299 | 1% (32) | 21% | $449,127 |
| 2014 | 3,472 | 292 | 3% (88) | 23% | $420,275 |
| 2013 | 3,939 | 285 | 2% (69) | 24% | $454,648 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Velphoro | 14 | $67,223 | $4,802 |
| Lokelma | 110 | $61,480 | $559 |
| Procrit | 65 | $54,906 | $845 |
| Farxiga | 44 | $35,745 | $812 |
| Jardiance | 16 | $21,394 | $1,337 |
| Veltassa | 13 | $9,825 | $756 |
| Cinacalcet | 11 | $6,636 | $603 |
| Calcium Acetate | 65 | $5,286 | $81 |
| Losartan | 126 | $2,354 | $19 |
| Labetalol | 37 | $2,287 | $62 |
| Nifedipine Er | 24 | $2,146 | $89 |
| Clonidine | 15 | $1,859 | $124 |
| Amlodipine Besylate | 155 | $1,633 | $11 |
| Potassium Chloride | 44 | $1,319 | $30 |
| Ondansetron | 13 | $1,170 | $90 |
| Furosemide | 127 | $936 | $7 |
| Hydralazine | 55 | $913 | $17 |
| Calcitriol | 26 | $738 | $28 |
| Benazepril | 39 | $684 | $18 |
| Diltiazem 24hr Er (Cd) | 11 | $682 | $62 |
| Carvedilol | 23 | $544 | $24 |
| Lisinopril | 41 | $432 | $11 |
| Glipizide Er | 19 | $411 | $22 |
| Atorvastatin | 33 | $406 | $12 |
| Allopurinol | 36 | $403 | $11 |
| Omeprazole | 14 | $329 | $23 |
| Prednisone | 36 | $283 | $8 |
| Sulfamethoxazole-Trimethoprim | 12 | $281 | $23 |
| Lovastatin | 15 | $279 | $19 |
| Hydrochlorothiazide | 45 | $240 | $5 |
| Clonidine | 11 | $238 | $22 |
| Gabapentin | 12 | $127 | $11 |
| Simvastatin | 12 | $119 | $10 |
| Olmesartan Medoxomil | 12 | $102 | $9 |
| Ciprofloxacin | 18 | $62 | $3 |
2022: 28 drugs
| Sevelamer Carbonate | 16 | $15,097 | $944 |
| Procrit | 11 | $14,137 | $1,285 |
| Lokelma | 16 | $9,786 | $612 |
| Calcium Acetate | 71 | $6,886 | $97 |
| Clonidine | 11 | $3,518 | $320 |
| Losartan | 170 | $2,507 | $15 |
| Nifedipine Er | 24 | $1,859 | $77 |
| Labetalol | 11 | $1,851 | $168 |
| Amlodipine Besylate | 177 | $1,505 | $9 |
| Potassium Chloride | 57 | $1,382 | $24 |
| Midodrine | 11 | $869 | $79 |
| Alprazolam | 11 | $846 | $77 |
| Ondansetron | 12 | $630 | $52 |
| Hydralazine | 47 | $610 | $13 |
| Benazepril | 48 | $603 | $13 |
| Furosemide | 107 | $591 | $6 |
| Omeprazole | 20 | $489 | $24 |
| Clonidine | 22 | $392 | $18 |
| Calcitriol | 26 | $373 | $14 |
| Lisinopril | 43 | $329 | $8 |
| Allopurinol | 31 | $318 | $10 |
| Hydrochlorothiazide | 57 | $245 | $4 |
| Atorvastatin | 23 | $243 | $11 |
| Lovastatin | 11 | $210 | $19 |
| Prednisone | 30 | $197 | $7 |
| Metoprolol | 15 | $130 | $9 |
| Spironolactone | 12 | $116 | $10 |
| Ciprofloxacin | 12 | $59 | $5 |
2021: 34 drugs
| Sevelamer Carbonate | 43 | $12,882 | $300 |
| Calcium Acetate | 72 | $8,538 | $119 |
| Clonidine | 25 | $4,611 | $184 |
| Cinacalcet | 13 | $4,086 | $314 |
| Labetalol | 37 | $3,667 | $99 |
| Sodium Polystyrene Sulfonate | 22 | $2,178 | $99 |
| Losartan | 140 | $1,946 | $14 |
| Potassium Chloride | 50 | $1,655 | $33 |
| Hydralazine | 68 | $1,275 | $19 |
| Amlodipine Besylate | 161 | $990 | $6 |
| Nifedipine Er | 17 | $919 | $54 |
| Pregabalin | 15 | $859 | $57 |
| Tacrolimus | 12 | $843 | $70 |
| Calcitriol | 35 | $766 | $22 |
| Alprazolam | 18 | $727 | $40 |
| Midodrine | 11 | $573 | $52 |
| Furosemide | 98 | $509 | $5 |
| Benazepril | 58 | $450 | $8 |
| Clonidine | 25 | $428 | $17 |
| Omeprazole | 24 | $397 | $17 |
| Atorvastatin | 30 | $373 | $12 |
| Lidocaine-Prilocaine | 19 | $355 | $19 |
| Allopurinol | 30 | $339 | $11 |
| Spironolactone | 28 | $297 | $11 |
| Levothyroxine | 11 | $294 | $27 |
| Lisinopril | 35 | $232 | $7 |
| Metoprolol | 18 | $213 | $12 |
| Prednisone | 31 | $202 | $7 |
| Metformin | 25 | $158 | $6 |
| Minoxidil | 15 | $141 | $9 |
| Hydrochlorothiazide | 32 | $138 | $4 |
| Metoclopramide | 12 | $126 | $11 |
| Carvedilol | 11 | $119 | $11 |
| Pantoprazole | 12 | $93 | $8 |
2020: 34 drugs
| Renvela | 24 | $55,294 | $2,304 |
| Sevelamer Carbonate | 37 | $12,524 | $338 |
| Calcium Acetate | 71 | $5,869 | $83 |
| Clonidine | 38 | $5,555 | $146 |
| Labetalol | 48 | $3,067 | $64 |
| Sodium Polystyrene Sulfonate | 24 | $2,428 | $101 |
| Hydralazine | 73 | $2,017 | $28 |
| Potassium Chloride | 59 | $2,010 | $34 |
| Losartan | 164 | $1,723 | $11 |
| Tacrolimus | 15 | $1,653 | $110 |
| Nifedipine Er | 13 | $1,427 | $110 |
| Furosemide | 201 | $1,215 | $6 |
| Repaglinide | 13 | $1,137 | $87 |
| Amlodipine Besylate | 166 | $976 | $6 |
| Levothyroxine | 29 | $940 | $32 |
| Calcitriol | 28 | $637 | $23 |
| Atorvastatin | 43 | $574 | $13 |
| Clonidine | 34 | $475 | $14 |
| Benazepril | 46 | $408 | $9 |
| Allopurinol | 39 | $378 | $10 |
| Gentamicin Sulfate | 11 | $348 | $32 |
| Warfarin | 16 | $291 | $18 |
| Prednisone | 39 | $242 | $6 |
| Alprazolam | 28 | $236 | $8 |
| Finasteride | 16 | $234 | $15 |
| Metoprolol | 19 | $230 | $12 |
| Atenolol | 18 | $223 | $12 |
| Citalopram Hbr | 13 | $213 | $16 |
| Spironolactone | 17 | $213 | $13 |
| Metformin | 26 | $201 | $8 |
| Lisinopril | 26 | $177 | $7 |
| Carvedilol | 16 | $149 | $9 |
| Hydrochlorothiazide | 22 | $105 | $5 |
| Pantoprazole | 17 | $104 | $6 |
2019: 40 drugs
| Renvela | 24 | $63,659 | $2,652 |
| Auryxia | 17 | $17,914 | $1,054 |
| Sevelamer Carbonate | 27 | $16,622 | $616 |
| Calcium Acetate | 81 | $9,877 | $122 |
| Eliquis | 15 | $6,722 | $448 |
| Labetalol | 72 | $3,946 | $55 |
| Clonidine | 16 | $2,803 | $175 |
| Losartan | 164 | $2,326 | $14 |
| Potassium Chloride | 49 | $2,295 | $47 |
| Nifedipine Er | 26 | $2,186 | $84 |
| Amlodipine Besylate | 173 | $2,012 | $12 |
| Hydralazine | 64 | $1,512 | $24 |
| Furosemide | 201 | $1,508 | $8 |
| Levothyroxine | 50 | $1,235 | $25 |
| Sodium Polystyrene Sulfonate | 11 | $1,125 | $102 |
| Clonidine | 47 | $952 | $20 |
| Repaglinide | 13 | $949 | $73 |
| Calcitriol | 42 | $938 | $22 |
| Benazepril | 61 | $692 | $11 |
| Allopurinol | 46 | $650 | $14 |
| Prednisone | 57 | $597 | $10 |
| Atorvastatin | 48 | $552 | $11 |
| Warfarin | 33 | $495 | $15 |
| Finasteride | 16 | $485 | $30 |
| Minoxidil | 19 | $478 | $25 |
| Tamsulosin | 20 | $419 | $21 |
| Metoprolol | 28 | $403 | $14 |
| Carvedilol | 22 | $348 | $16 |
| Atenolol | 33 | $318 | $10 |
| Metformin | 27 | $313 | $12 |
| Omeprazole | 22 | $296 | $13 |
| Pantoprazole | 20 | $219 | $11 |
| Simvastatin | 12 | $211 | $18 |
| Ciprofloxacin | 16 | $194 | $12 |
| Amiodarone | 16 | $183 | $11 |
| Lisinopril | 29 | $183 | $6 |
| Hydrochlorothiazide | 52 | $171 | $3 |
| Citalopram Hbr | 13 | $149 | $11 |
| Alprazolam | 12 | $131 | $11 |
| Famotidine | 11 | $104 | $9 |
2018: 43 drugs
| Renvela | 29 | $48,594 | $1,676 |
| Sevelamer Carbonate | 31 | $27,750 | $895 |
| Sensipar | 16 | $26,004 | $1,625 |
| Procrit | 15 | $19,872 | $1,325 |
| Calcium Acetate | 142 | $12,703 | $89 |
| Januvia | 11 | $9,094 | $827 |
| Labetalol | 53 | $2,552 | $48 |
| Amlodipine Besylate | 178 | $1,776 | $10 |
| Hydralazine | 68 | $1,412 | $21 |
| Losartan | 110 | $1,296 | $12 |
| Sodium Polystyrene Sulfonate | 13 | $1,260 | $97 |
| Levothyroxine | 41 | $1,223 | $30 |
| Furosemide | 158 | $977 | $6 |
| Potassium Chloride | 31 | $966 | $31 |
| Calcitriol | 51 | $956 | $19 |
| Nifedipine Er | 19 | $921 | $48 |
| Clonidine | 56 | $829 | $15 |
| Repaglinide | 15 | $667 | $44 |
| Insulin | 14 | $638 | $46 |
| Benazepril | 56 | $627 | $11 |
| Tamsulosin | 14 | $530 | $38 |
| Allopurinol | 32 | $530 | $17 |
| Lidocaine-Prilocaine | 13 | $501 | $39 |
| Prednisone | 42 | $461 | $11 |
| Omeprazole | 25 | $457 | $18 |
| Finasteride | 11 | $423 | $38 |
| Warfarin | 32 | $384 | $12 |
| Atorvastatin | 38 | $370 | $10 |
| Minoxidil | 19 | $362 | $19 |
| Alprazolam | 19 | $352 | $19 |
| Carvedilol | 27 | $346 | $13 |
| Metformin | 30 | $292 | $10 |
| Metoprolol | 23 | $265 | $12 |
| Clopidogrel | 13 | $264 | $20 |
| Paroxetine | 16 | $259 | $16 |
| Lisinopril | 23 | $232 | $10 |
| Metoclopramide | 15 | $185 | $12 |
| Ondansetron | 11 | $173 | $16 |
| Amiodarone | 18 | $166 | $9 |
| Ciprofloxacin | 16 | $157 | $10 |
| Simvastatin | 17 | $143 | $8 |
| Atenolol | 19 | $106 | $6 |
| Hydrochlorothiazide | 27 | $85 | $3 |
2017: 50 drugs
| Sensipar | 65 | $118,611 | $1,825 |
| Renvela | 58 | $97,032 | $1,673 |
| Procrit | 17 | $17,189 | $1,011 |
| Calcium Acetate | 137 | $10,900 | $80 |
| Januvia | 12 | $9,069 | $756 |
| Lyrica | 12 | $5,378 | $448 |
| Clonidine | 13 | $3,409 | $262 |
| Novolin R | 14 | $2,148 | $153 |
| Labetalol | 34 | $1,880 | $55 |
| Potassium Chloride | 49 | $1,508 | $31 |
| Nifedipine Er | 47 | $1,482 | $32 |
| Levothyroxine | 37 | $1,134 | $31 |
| Sodium Polystyrene Sulfonate | 15 | $1,056 | $70 |
| Benazepril | 115 | $1,028 | $9 |
| Hydralazine | 57 | $934 | $16 |
| Insulin | 18 | $933 | $52 |
| Metolazone | 11 | $919 | $84 |
| Furosemide | 178 | $836 | $5 |
| Calcitriol | 49 | $792 | $16 |
| Valsartan | 19 | $786 | $41 |
| Losartan | 81 | $781 | $10 |
| Amlodipine Besylate | 174 | $774 | $4 |
| Diltiazem 24hr Er | 27 | $752 | $28 |
| Repaglinide | 13 | $606 | $47 |
| Allopurinol | 46 | $566 | $12 |
| Enalapril Maleate | 14 | $553 | $40 |
| Clonidine | 63 | $549 | $9 |
| Atorvastatin | 42 | $539 | $13 |
| Prednisone | 45 | $533 | $12 |
| Lidocaine-Prilocaine | 11 | $515 | $47 |
| Tamsulosin | 15 | $441 | $29 |
| Warfarin | 33 | $379 | $11 |
| Omeprazole | 34 | $335 | $10 |
| Metformin | 33 | $329 | $10 |
| Simvastatin | 43 | $326 | $8 |
| Clopidogrel | 23 | $297 | $13 |
| Finasteride | 27 | $296 | $11 |
| Minoxidil | 19 | $282 | $15 |
| Carvedilol | 28 | $230 | $8 |
| Metoprolol | 24 | $222 | $9 |
| Pravastatin | 13 | $204 | $16 |
| Lisinopril | 34 | $203 | $6 |
| Gabapentin | 16 | $171 | $11 |
| Metoclopramide | 23 | $163 | $7 |
| Alprazolam | 16 | $153 | $10 |
| Glipizide | 27 | $151 | $6 |
| Famotidine | 16 | $117 | $7 |
| Hydrochlorothiazide | 31 | $104 | $3 |
| Atenolol | 25 | $84 | $3 |
| Amiodarone | 11 | $71 | $6 |
2016: 53 drugs
| Renvela | 103 | $152,717 | $1,483 |
| Sensipar | 65 | $95,474 | $1,469 |
| Procrit | 14 | $18,638 | $1,331 |
| Calcium Acetate | 140 | $17,672 | $126 |
| Lantus | 32 | $10,894 | $340 |
| Novolog | 16 | $4,209 | $263 |
| Advair Diskus | 11 | $3,024 | $275 |
| Labetalol | 36 | $2,960 | $82 |
| Hydralazine | 70 | $1,473 | $21 |
| Levothyroxine | 46 | $1,329 | $29 |
| Benazepril | 131 | $1,306 | $10 |
| Valsartan | 25 | $1,275 | $51 |
| Furosemide | 218 | $1,233 | $6 |
| Sodium Polystyrene Sulfonate | 13 | $1,222 | $94 |
| Potassium Chloride | 34 | $1,062 | $31 |
| Calcitriol | 40 | $1,025 | $26 |
| Nifedipine Er | 27 | $1,025 | $38 |
| Amlodipine Besylate | 214 | $996 | $5 |
| Atorvastatin | 42 | $857 | $20 |
| Allopurinol | 51 | $777 | $15 |
| Losartan | 63 | $691 | $11 |
| Insulin | 18 | $680 | $38 |
| Clonidine | 65 | $668 | $10 |
| Omeprazole | 56 | $576 | $10 |
| Clopidogrel | 46 | $553 | $12 |
| Prednisone | 52 | $548 | $11 |
| Pravastatin | 18 | $498 | $28 |
| Metformin | 28 | $458 | $16 |
| Warfarin | 48 | $456 | $10 |
| Finasteride | 31 | $450 | $15 |
| Isosorbide Mononitrate Er | 17 | $428 | $25 |
| Tamsulosin | 16 | $410 | $26 |
| Carvedilol | 40 | $407 | $10 |
| Lisinopril | 51 | $387 | $8 |
| Repaglinide | 11 | $360 | $33 |
| Minoxidil | 16 | $348 | $22 |
| Oxybutynin Chloride | 11 | $316 | $29 |
| Simvastatin | 32 | $304 | $10 |
| Gabapentin | 21 | $286 | $14 |
| Metoprolol | 30 | $266 | $9 |
| Pantoprazole | 18 | $233 | $13 |
| Atenolol | 24 | $176 | $7 |
| Alendronate | 13 | $160 | $12 |
| Fluticasone Propionate | 11 | $156 | $14 |
| Glipizide | 16 | $152 | $10 |
| Alprazolam | 32 | $149 | $5 |
| Ropinirole | 11 | $116 | $11 |
| Amiodarone | 13 | $106 | $8 |
| Hydrochlorothiazide | 27 | $103 | $4 |
| Lorazepam | 17 | $95 | $6 |
| Metoclopramide | 13 | $87 | $7 |
| Ciprofloxacin | 15 | $85 | $6 |
| Famotidine | 13 | $47 | $4 |
2015: 70 drugs
| Renvela | 117 | $168,286 | $1,438 |
| Sensipar | 74 | $81,700 | $1,104 |
| Procrit | 13 | $22,844 | $1,757 |
| Calcium Acetate | 167 | $20,506 | $123 |
| Lantus | 53 | $18,537 | $350 |
| Novolog | 22 | $6,511 | $296 |
| Clonidine | 21 | $4,928 | $235 |
| Labetalol | 64 | $4,009 | $63 |
| Tacrolimus | 20 | $2,832 | $142 |
| Advair Diskus | 11 | $2,704 | $246 |
| Valsartan | 28 | $2,306 | $82 |
| Sodium Polystyrene Sulfonate | 16 | $1,756 | $110 |
| Diltiazem Er | 35 | $1,629 | $47 |
| Levothyroxine | 63 | $1,623 | $26 |
| Calcitriol | 53 | $1,544 | $29 |
| Proair Hfa | 23 | $1,360 | $59 |
| Potassium Chloride | 35 | $1,297 | $37 |
| Nifedipine Er | 26 | $1,292 | $50 |
| Benazepril | 111 | $1,221 | $11 |
| Furosemide | 207 | $1,200 | $6 |
| Hydralazine | 45 | $1,179 | $26 |
| Amlodipine Besylate | 209 | $1,149 | $5 |
| Mycophenolate Mofetil | 14 | $1,058 | $76 |
| Warfarin | 64 | $1,004 | $16 |
| Tamsulosin | 29 | $913 | $31 |
| Allopurinol | 51 | $889 | $17 |
| Losartan | 73 | $880 | $12 |
| Atorvastatin | 43 | $855 | $20 |
| Diltiazem 24hr Cd | 27 | $825 | $31 |
| Isosorbide Mononitrate Er | 29 | $750 | $26 |
| Clonidine | 75 | $674 | $9 |
| Omeprazole | 49 | $646 | $13 |
| Carvedilol | 52 | $622 | $12 |
| Clopidogrel | 40 | $558 | $14 |
| Prednisone | 52 | $534 | $10 |
| Lisinopril | 60 | $503 | $8 |
| Gabapentin | 39 | $490 | $13 |
| Isosorbide Dinitrate | 12 | $459 | $38 |
| Pravastatin | 14 | $452 | $32 |
| Lidocaine-Prilocaine | 13 | $451 | $35 |
| Metoprolol | 14 | $449 | $32 |
| Zolpidem | 34 | $417 | $12 |
| Repaglinide | 13 | $403 | $31 |
| Hydrocodone-Acetaminophen | 18 | $393 | $22 |
| Polyethylene Glycol 3350 | 19 | $354 | $19 |
| Simvastatin | 26 | $349 | $13 |
| Metoprolol | 38 | $342 | $9 |
| Midodrine | 13 | $326 | $25 |
| Diphenoxylate-Atropine | 13 | $298 | $23 |
| Glipizide | 39 | $291 | $7 |
| Minoxidil | 23 | $288 | $13 |
| Metformin | 15 | $286 | $19 |
| Pantoprazole | 30 | $285 | $10 |
| Nateglinide | 12 | $269 | $22 |
| Finasteride | 15 | $231 | $15 |
| Glipizide Er | 12 | $226 | $19 |
| Alprazolam | 43 | $210 | $5 |
| Hydrochlorothiazide | 42 | $195 | $5 |
| Paroxetine | 16 | $173 | $11 |
| Ropinirole | 11 | $170 | $15 |
| Fluticasone Propionate | 13 | $162 | $12 |
| Famotidine | 32 | $161 | $5 |
| Alendronate | 13 | $155 | $12 |
| Atenolol | 21 | $120 | $6 |
| Metoclopramide | 18 | $117 | $6 |
| Lorazepam | 16 | $87 | $5 |
| Gemfibrozil | 11 | $84 | $8 |
| Temazepam | 18 | $84 | $5 |
| Triamterene-Hydrochlorothiazid | 11 | $71 | $6 |
| Sulfamethoxazole-Trimethoprim | 12 | $60 | $5 |
2014: 77 drugs
| Renvela | 126 | $140,608 | $1,116 |
| Sensipar | 67 | $57,819 | $863 |
| Procrit | 31 | $26,563 | $857 |
| Calcium Acetate | 164 | $21,948 | $134 |
| Renagel | 11 | $18,903 | $1,718 |
| Lantus | 59 | $17,651 | $299 |
| Diovan | 47 | $9,238 | $197 |
| Novolog | 31 | $8,763 | $283 |
| Clonidine | 18 | $6,078 | $338 |
| Labetalol | 44 | $4,614 | $105 |
| Sps | 28 | $3,739 | $134 |
| Cyclosporine Modified | 11 | $2,259 | $205 |
| Desmopressin Acetate | 14 | $2,087 | $149 |
| Nifedipine Er | 33 | $1,965 | $60 |
| Diltiazem Er | 34 | $1,699 | $50 |
| Valsartan | 12 | $1,674 | $139 |
| Hydralazine | 44 | $1,533 | $35 |
| Levothyroxine | 65 | $1,393 | $21 |
| Clonidine | 131 | $1,369 | $10 |
| Benazepril | 123 | $1,364 | $11 |
| Amlodipine Besylate | 212 | $1,340 | $6 |
| Calcitriol | 31 | $1,289 | $42 |
| Isosorbide Dinitrate | 11 | $1,281 | $116 |
| Furosemide | 192 | $1,205 | $6 |
| Omeprazole | 65 | $1,033 | $16 |
| Mycophenolate Mofetil | 12 | $1,002 | $84 |
| Losartan | 63 | $935 | $15 |
| Proair Hfa | 15 | $934 | $62 |
| Metolazone | 14 | $922 | $66 |
| Diltiazem 24hr Cd | 20 | $892 | $45 |
| Repaglinide | 13 | $863 | $66 |
| Warfarin | 62 | $861 | $14 |
| Gabapentin | 49 | $789 | $16 |
| Atorvastatin | 37 | $731 | $20 |
| Hydrocodone-Acetaminophen | 45 | $728 | $16 |
| Lisinopril | 62 | $705 | $11 |
| Glipizide | 57 | $665 | $12 |
| Minoxidil | 33 | $655 | $20 |
| Acarbose | 12 | $634 | $53 |
| Pravastatin | 16 | $615 | $38 |
| Carvedilol | 52 | $601 | $12 |
| Isosorbide Mononitrate Er | 31 | $594 | $19 |
| Prednisone | 41 | $547 | $13 |
| Clopidogrel | 54 | $542 | $10 |
| Tamsulosin | 21 | $502 | $24 |
| Simvastatin | 53 | $493 | $9 |
| Bd Ultra-Fine Pen Needle | 14 | $492 | $35 |
| Metoprolol | 62 | $461 | $7 |
| Metformin | 38 | $453 | $12 |
| Klor-Con M20 | 16 | $434 | $27 |
| Doxazosin Mesylate | 15 | $402 | $27 |
| Zolpidem | 40 | $373 | $9 |
| Alprazolam | 59 | $363 | $6 |
| Polyethylene Glycol 3350 | 20 | $313 | $16 |
| Diphenoxylate-Atropine | 13 | $298 | $23 |
| Insulin | 13 | $281 | $22 |
| Amitriptyline | 13 | $268 | $21 |
| Allopurinol | 31 | $264 | $9 |
| Gentamicin Sulfate | 11 | $259 | $24 |
| Paroxetine | 12 | $256 | $21 |
| Pantoprazole | 24 | $235 | $10 |
| Diltiazem | 18 | $235 | $13 |
| Finasteride | 21 | $219 | $10 |
| Clonazepam | 13 | $206 | $16 |
| Alendronate | 25 | $183 | $7 |
| Famotidine | 36 | $171 | $5 |
| Triamterene-Hydrochlorothiazid | 21 | $170 | $8 |
| Ranitidine | 18 | $145 | $8 |
| Atenolol | 15 | $138 | $9 |
| Metoclopramide | 21 | $136 | $6 |
| Lorazepam | 24 | $131 | $5 |
| Temazepam | 19 | $103 | $5 |
| Amiodarone | 11 | $95 | $9 |
| Diazepam | 13 | $91 | $7 |
| Amoxicillin | 18 | $83 | $5 |
| Hydrochlorothiazide | 13 | $69 | $5 |
| Tramadol | 18 | $66 | $4 |
2013: 88 drugs
| Renvela | 151 | $139,865 | $926 |
| Sensipar | 49 | $53,408 | $1,090 |
| Procrit | 44 | $43,990 | $1,000 |
| Renagel | 27 | $38,601 | $1,430 |
| Calcium Acetate | 138 | $15,684 | $114 |
| Lantus | 65 | $13,333 | $205 |
| Diovan | 65 | $11,736 | $181 |
| Novolog | 38 | $8,307 | $219 |
| Clonidine | 27 | $8,076 | $299 |
| Fosrenol | 11 | $8,037 | $731 |
| Labetalol | 54 | $5,713 | $106 |
| Humalog | 28 | $4,889 | $175 |
| Sps | 38 | $4,411 | $116 |
| Novolog Mix 70-30 Flexpen | 11 | $3,386 | $308 |
| Clopidogrel | 67 | $3,257 | $49 |
| Lantus Solostar | 17 | $2,640 | $155 |
| Sodium Polystyrene Sulfonate | 19 | $2,621 | $138 |
| Diltiazem Er | 48 | $2,601 | $54 |
| Calcitriol | 49 | $2,519 | $51 |
| Advair Diskus | 11 | $2,384 | $217 |
| Benazepril | 161 | $2,258 | $14 |
| Omeprazole | 113 | $2,201 | $19 |
| Atorvastatin | 57 | $1,958 | $34 |
| Hydralazine | 43 | $1,909 | $44 |
| Nifedipine Er | 22 | $1,861 | $85 |
| Clonidine | 140 | $1,765 | $13 |
| Furosemide | 205 | $1,574 | $8 |
| Amiodarone | 13 | $1,557 | $120 |
| Amlodipine Besylate | 214 | $1,423 | $7 |
| Minoxidil | 51 | $1,337 | $26 |
| Cyclosporine Modified | 11 | $1,336 | $121 |
| Diltiazem 24hr Cd | 30 | $1,132 | $38 |
| Glipizide | 97 | $1,095 | $11 |
| Mycophenolate Mofetil | 11 | $1,034 | $94 |
| Proair Hfa | 19 | $1,032 | $54 |
| Losartan | 55 | $971 | $18 |
| Paroxetine | 17 | $957 | $56 |
| Gabapentin | 51 | $953 | $19 |
| Levothyroxine | 65 | $919 | $14 |
| Potassium Chloride | 31 | $824 | $27 |
| Carvedilol | 62 | $814 | $13 |
| Klor-Con M20 | 32 | $763 | $24 |
| Warfarin | 43 | $685 | $16 |
| Simvastatin | 66 | $665 | $10 |
| Bd Ultra-Fine Pen Needle | 20 | $654 | $33 |
| Isosorbide Mononitrate Er | 27 | $637 | $24 |
| Metoprolol | 15 | $626 | $42 |
| Insulin | 17 | $626 | $37 |
| Diltiazem 24hr Er | 12 | $607 | $51 |
| Lisinopril | 48 | $597 | $12 |
| Levetiracetam | 12 | $560 | $47 |
| Acarbose | 11 | $542 | $49 |
| Zolpidem | 85 | $517 | $6 |
| Metformin | 31 | $454 | $15 |
| Lidocaine-Prilocaine | 13 | $431 | $33 |
| Fenofibrate | 11 | $427 | $39 |
| Finasteride | 22 | $410 | $19 |
| Pravastatin | 22 | $404 | $18 |
| Metoprolol | 50 | $393 | $8 |
| Tamsulosin | 13 | $383 | $29 |
| Polyethylene Glycol 3350 | 18 | $351 | $20 |
| Insulin | 19 | $348 | $18 |
| Hydrocodone-Acetaminophen | 42 | $347 | $8 |
| Alprazolam | 51 | $338 | $7 |
| Pantoprazole | 21 | $331 | $16 |
| Fluoxetine | 12 | $289 | $24 |
| Spironolactone | 15 | $273 | $18 |
| Prednisone | 40 | $260 | $7 |
| Glipizide Xl | 24 | $257 | $11 |
| Famotidine | 36 | $238 | $7 |
| Doxazosin Mesylate | 20 | $232 | $12 |
| Atenolol | 23 | $224 | $10 |
| Diphenoxylate-Atropine | 23 | $220 | $10 |
| Gentamicin Sulfate | 16 | $218 | $14 |
| Allopurinol | 29 | $215 | $7 |
| Clonazepam | 12 | $194 | $16 |
| Lorazepam | 26 | $188 | $7 |
| Alendronate | 24 | $181 | $8 |
| Diltiazem | 13 | $165 | $13 |
| Ciprofloxacin | 20 | $149 | $7 |
| Metoclopramide | 18 | $113 | $6 |
| Temazepam | 20 | $105 | $5 |
| Pacerone | 11 | $100 | $9 |
| Amitriptyline | 13 | $93 | $7 |
| Amoxicillin | 12 | $88 | $7 |
| Ranitidine | 11 | $88 | $8 |
| Triamterene-Hctz | 12 | $82 | $7 |
| Hydrochlorothiazide | 18 | $63 | $4 |
Money from drug and device companies
$70 in 2025
| 2025 | 2 | 3 | None | $70 |
| 2024 | 3 | 8 | None | $608 |
| 2023 | 3 | 7 | None | $326 |
| 2021 | 2 | 2 | None | $203 |
| 2019 | 2 | 3 | None | $165 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | Jynarque | $44 | 2 payments
|
| Ardelyx | Ibsrela | $27 | 1 payment
|
See all 3 published payments
| Ardelyx | Meals · 2025-11-13 | Ibsrela | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-06-26 | Jynarque | $19 |
| Otsuka America Pharmaceutical | Meals · 2025-03-18 | Jynarque | $25 |
See earlier years (2024, 2023, 2021, 2019)
2024: $608
| Sanofi-Aventis U.S. | Thymoglobulin | $425 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $156 | 3 payments
|
| Vifor Pharma | None | $28 | 1 payment
|
2023: $326
| AstraZeneca Pharmaceuticals LP | Farxiga | $192 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $120 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $14 | 1 payment
|
2021: $203
| Aurinia Pharma U.S. | Lupkynis | $117 | 1 payment
|
| GlaxoSmithKline | Benlysta | $86 | 1 payment
|
2019: $165
| Genentech USA | Rituxan | $136 | 1 payment
|
| Amgen | Parsabiv | $29 | 2 payments
|
Professional record
- NPI
- 1205814837
- Licence
- CA A55053California A55053: Current · expires 2027-10-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A550530
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 14350 East Whittier Blvd, 101, Whittier, CA, 90605
- NPI first listed
- 2006-01-04
- NPI last updated
- 2009-07-10
This is when the NPI record was last certified, not a medical board exam.